Bionaut Labs
Bionaut Labs is focused on revolutionizing the treatment of central nervous system disorders with its Bionaut precision medicine treatment modality that uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted disease areas. With the Bionaut medical modality, Bionaut Labs can transform the way the biopharmaceutical industry develops treatments, allowing the Company to engineer the therapeutic index for better efficacy and safety. Led by a world-class team of medical, engineering, and drug development experts, Bionaut Labs' is headquartered in Los Angeles, California, with additional R&D sites in Israel and at the Max Planck Institute in Germany.
About Bionaut Labs
Founded
2016Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$43MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
38NAICs Code
33Location
City
Los AngelesState
CaliforniaCountry
United StatesBionaut Labs
Find your buyer within Bionaut Labs